Phase I/II Trial of Pre-Op IG-IMPT or IMRT with SIB for Retroperitoneal Sarcomas

What is the Purpose of this Study?

We are doing this study to look at the use of IG-IMRT as a treatment for retroperitoneal sarcomas.
What is the Condition Being Studied?
Retroperitoneal Sarcomas

Who Can Participate in this Study?

Adults who:

- Are diagnosed with primary soft tissue sarcoma of the retroperitoneum

- Have a life expectancy of greater than 2 years

Age Group
Adults
Participating Institutions

What is Involved?

If you choose to join this study, you will:

- Undergo radiation therapy using IG-IMRT before surgery for the removal of your tumor.

- Receive a standard dose of radiation that will be given to the majority of the tumor and at the same time, a higher dose of radiation will be given to certain areas of the tumor identified as higher risks.

- Schedule your surgery following radiation therapy with your surgeon.

- Be involved in the study for about 6 months.

Study Details

Full Title
Phase I/II Trial of Pre-Operative Image Guided Intensity Modulated Proton Radiation Therapy (IMPT) or Photon (IMRT) with Simultaneously Integrated Boost to the High Risk Margin for Retroperitoneal Sarcomas
Principal Investigator

Contacts
Protocol Number
IRB:
PRO00075846

NCT:
NCT01659203
ClinicalTrials.gov
View on ClinicalTrials.gov